Differentiating Osteoporosis from other diseases: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(13 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Osteoporosis}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Osteoporosis]]
{{CMG}}; {{AE}}{{EG}}, {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:ravitheja.g@gmail.com]  
{{CMG}}; {{AE}}{{EG}}, {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:ravitheja.g@gmail.com]  


Line 6: Line 6:
Osteoporosis must be differentiated from other [[diseases]] that cause a decrease in the [[Bone mineral density|bone mineral density (BMD)]], such as idiopathic transient osteoporosis of [[hip]], [[osteomalacia]], [[scurvy]], [[osteogenesis imperfecta]], [[multiple myeloma]], [[homocystinuria]], and hypermetabolic resorptive osteoporosis.
Osteoporosis must be differentiated from other [[diseases]] that cause a decrease in the [[Bone mineral density|bone mineral density (BMD)]], such as idiopathic transient osteoporosis of [[hip]], [[osteomalacia]], [[scurvy]], [[osteogenesis imperfecta]], [[multiple myeloma]], [[homocystinuria]], and hypermetabolic resorptive osteoporosis.


==Differentiating osteoporosis from other diseases==
==Differentiating Osteoporosis from other Diseases==
[[Osteoporosis]] must be differentiated from other [[diseases]] that cause a decrease in the [[Bone mineral density|bone mineral density (BMD)]], such as idiopathic transient osteoporosis of [[hip]], [[osteomalacia]], [[scurvy]], [[osteogenesis imperfecta]], [[multiple myeloma]], [[homocystinuria]], and hypermetabolic resorptive osteoporosis. The major similarities and differences among the diseases are discussed in the following table:
[[Osteoporosis]] must be differentiated from other [[diseases]] that cause a decrease in the [[Bone mineral density|bone mineral density (BMD)]], such as idiopathic transient osteoporosis of [[hip]], [[osteomalacia]], [[scurvy]], [[osteogenesis imperfecta]], [[multiple myeloma]], [[homocystinuria]], and hypermetabolic resorptive osteoporosis. The major similarities and differences among the diseases are discussed in the following table:
{| align="center"
 
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |Diseases
! colspan="5" |History and Physical Examination
! colspan="3" |Imaging findings
! colspan="4" |Laboratory Findings
! rowspan="2" |Other Findings
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Bone pain
!Fatigue
!Short stature
!Scoliosis
!Bone tenderness
!BMD
!Sub-chondral cortical loss
!Bone fracture
!Vitamin C
!Ca
!Vitamin D
!ALKph
|-
|-
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Osteoporosis'''
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center"" "
| style="background: #F5F5F5; padding: 5px;" | +
| valign="top" |
| style="background: #F5F5F5; padding: 5px;" | -
|+
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differential Diagnosis}}
| style="background: #F5F5F5; padding: 5px;" | -
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Similar Features}}
| style="background: #F5F5F5; padding: 5px;" | +
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Differentiating Features}}
| style="background: #F5F5F5; padding: 5px;" |↓↓↓
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''Osteoporosis'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Idiopathic]] transient osteoporosis of [[Hip (anatomy)|hip]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | +
* On physical examination, demonstrates acute musculoskeletal pain, if [[Bone fracture|fracture]] happened
| style="background: #F5F5F5; padding: 5px;" | -
* On imaging studies, demonstrates severe decrease in [[Bone mineral density|BMD]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Idiopathic]] transient osteoporosis of [[Hip (anatomy)|hip]]'''
| style="background: #F5F5F5; padding: 5px;" |↓↓
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | +
* On physical examination, demonstrates acute [[hip]] pain
| style="background: #F5F5F5; padding: 5px;" | -
* On imaging studies, demonstrates sub-chondral [[Cortical bone|cortical]] loss and diffuse [[osteopenia]] of the [[femoral]] neck
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On history, demonstrates mostly involvement of [[pregnant]] women and young men
| style="background: #F5F5F5; padding: 5px;" | -
* On history, demonstrates to be [[self-limiting]] in 6-8 months
| style="background: #F5F5F5; padding: 5px;" |↑
| style="background: #F5F5F5; padding: 5px;" |
* Mostly [[pregnant]] women
* [[Self-limiting]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteomalacia]]'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Osteomalacia]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On physical examination, demonstrates diffuse [[bone]] [[pain]], fatigue, and [[fractures]] are the common symptoms
| style="background: #F5F5F5; padding: 5px;" | -
* On imaging studies, demonstrates low [[Bone mineral density|bone mineral density (BMD)]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On imaging studies, demonstrate the brief [[Bone loss|bone mass loss]] in [[bones]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |↓
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |↓
| style="background: #F5F5F5; padding: 5px;" |↓
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Scurvy]]'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Scurvy]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | +
* On physical examination, demonstrates [[bone pain]] and frequent [[fractures]] due to brittle [[bone]]
| style="background: #F5F5F5; padding: 5px;" | +
* On imaging studies, demonstrates low [[Bone mineral density|bone mineral density (BMD)]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On physical examination, demonstrates other [[mucosal]] disruption symptoms, such as [[bleeding gums]]
| style="background: #F5F5F5; padding: 5px;" | -
* On imaging studies, demonstrates normal [[Bone mineral density|bone mineral density (BMD)]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Mucosal]] bleeding
* Bleeding [[Gingiva|gums]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteogenesis imperfecta]]'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Osteogenesis imperfecta]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On physical examination, demonstrates [[short stature]], [[scoliosis]], and propensity for [[Bone fracture|fractures]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | +
* On physical examination, demonstrates [[tooth]] defects, [[Hearing impairment|hearing defects]], and blue [[sclera]]
| style="background: #F5F5F5; padding: 5px;" | +
* On imaging studies, demonstrates near normal [[Bone mineral density|bone mineral density (BMD)]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* Tooth defect
* Hearing problems
* [[Blue sclera]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Multiple myeloma]]'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Multiple myeloma]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | +
* On physical examination, demonstrates diffuse [[bone]] pain and [[tenderness]]
| style="background: #F5F5F5; padding: 5px;" | +
* On imaging studies, demonstrates osteolytic lesions in the [[bones]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On laboratory studies, demonstrates monoclonal [[IgM]] overload in [[electrophoresis]], and also [[Bence-Jones protein]] in urine
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |↓
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |↑
| style="background: #F5F5F5; padding: 5px;" |
* Bone [[lytic]] lesions
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Homocystinuria]]'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Homocystinuria]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | +
* On physical examination, demonstrates diffuse [[bone]] [[pain]] and [[musculoskeletal]] symptoms
| style="background: #F5F5F5; padding: 5px;" | -
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="background: #F5F5F5; padding: 5px;" | -
* On physical examination, demonstrates [[visual impairment]]  
| style="background: #F5F5F5; padding: 5px;" | -
* On laboratory studies, demonstrates high amounts of [[homocysteine]] in [[urine]]
| style="background: #F5F5F5; padding: 5px;" | -
|}
| style="background: #F5F5F5; padding: 5px;" |↓
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Visual impairment]]
* [[Homocysteine]] in [[urine]]
|}
|}
==='''Idiopathic transient osteoporosis of hip'''===
* It was initially thought to be seen in women during the [[third trimester]] of [[pregnancy]] but it is seen also in middle-aged men.
* Acute [[hip]] pain is the main feature of the [[disease]], usually [[Self-limiting|self-limited]] and resolves after 6-8 months.
* Sometimes it may be explained as early or benign [[Avascular necrosis|avascular necrosis (AVN)]].
* Subchondral [[Cortical bone|cortical]] loss and diffuse [[osteopenia]] of the [[femoral]] head and neck are the [[pathognomonic]] features.
* Treatment includes joint protection, limited weight bearing, and [[NSAID]]s.<ref name="pmid12812240">{{cite journal| author=Balakrishnan A, Schemitsch EH, Pearce D, McKee MD| title=Distinguishing transient osteoporosis of the hip from avascular necrosis. | journal=Can J Surg | year= 2003 | volume= 46 | issue= 3 | pages= 187-92 | pmid=12812240 | doi= | pmc=3211740 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12812240  }} </ref>


=== '''Idiopathic transient osteoporosis of hip''' ===
=== '''Osteomalacia''' ===
Primarily, it is thought to be seen most often in women during the [[third trimester]] of [[pregnancy]]; but it is seen also in middle-aged men. Acute [[hip]] pain is the main feature of the [[disease]]; usually [[Self-limiting|self-limited]] and resolves after 6-8 months. Sometimes it may be explained as early or benign [[Avascular necrosis|avascular necrosis (AVN)]]. Subchondral [[Cortical bone|cortical]] loss and diffuse [[osteopenia]] of the [[femoral]] head and neck are the [[pathognomonic]] features. Treatment includes joint protection, limited weight bearing, and [[NSAID]]s.<ref name="pmid12812240">{{cite journal| author=Balakrishnan A, Schemitsch EH, Pearce D, McKee MD| title=Distinguishing transient osteoporosis of the hip from avascular necrosis. | journal=Can J Surg | year= 2003 | volume= 46 | issue= 3 | pages= 187-92 | pmid=12812240 | doi= | pmc=3211740 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12812240  }} </ref>
* Osteomalacia is the inability to mineralize the newly formed [[bone]] matrix, caused by the deficiency of [[vitamin D]] in adults.  


=== '''Osteomalacia''' ===
* It is due to low turn-over of [[bone]] in which [[osteoblasts]] are deficient.  
Inability to mineralize the newly formed [[bone]] matrix, which is caused by the deficiency of [[vitamin D]] in adults. It is kind of low-turnover [[bone]] disease, in which [[osteoblasts]] are always scant. Diffuse [[bone]] pain, fatigue, and [[fractures]] are the common symptoms. It also can progress to [[osteoporosis]].<ref name="pmid27746441">{{cite journal| author=Hiramatsu R, Ubara Y, Sawa N, Hasegawa E, Kawada M, Imafuku A et al.| title=Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir. | journal=Intern Med | year= 2016 | volume= 55 | issue= 20 | pages= 3013-3019 | pmid=27746441 | doi=10.2169/internalmedicine.55.6806 | pmc=5109571 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27746441  }} </ref>
* Diffuse [[bone]] pain, fatigue, and [[fractures]] are the most common symptoms.  
* It can also progress to [[osteoporosis]].<ref name="pmid27746441">{{cite journal| author=Hiramatsu R, Ubara Y, Sawa N, Hasegawa E, Kawada M, Imafuku A et al.| title=Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir. | journal=Intern Med | year= 2016 | volume= 55 | issue= 20 | pages= 3013-3019 | pmid=27746441 | doi=10.2169/internalmedicine.55.6806 | pmc=5109571 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27746441  }} </ref>


=== '''Scurvy''' ===
=== '''Scurvy''' ===
Regarding the major role of [[vitamin C]] in the biosynthesis of [[collagen]], its deficiency may lead to dysfunction of every [[collagen]] containing [[Organ (anatomy)|organs]]; such as [[bones]]. New [[bone]] formation is disturbed and the old [[bone]] becomes brittle due to lack and poor quality of [[collagen]]. Treatment is [[vitamin C]] replacement.<ref name="pmid6309911">{{cite journal| author=Chojkier M, Spanheimer R, Peterkofsky B| title=Specifically decreased collagen biosynthesis in scurvy dissociated from an effect on proline hydroxylation and correlated with body weight loss. In vitro studies in guinea pig calvarial bones. | journal=J Clin Invest | year= 1983 | volume= 72 | issue= 3 | pages= 826-35 | pmid=6309911 | doi=10.1172/JCI111053 | pmc=1129247 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6309911  }} </ref>
* [[Vitamin C]] deficiency causes defective [[collagen]] synthesis, leading to dysfunction of every [[collagen]] containing [[Organ (anatomy)|organ]] such as [[bones]].  
* New [[bone]] formation is disturbed and the old [[bone]] becomes brittle due to lack and poor quality of [[collagen]].  
* Treatment is [[vitamin C]] replacement.<ref name="pmid6309911">{{cite journal| author=Chojkier M, Spanheimer R, Peterkofsky B| title=Specifically decreased collagen biosynthesis in scurvy dissociated from an effect on proline hydroxylation and correlated with body weight loss. In vitro studies in guinea pig calvarial bones. | journal=J Clin Invest | year= 1983 | volume= 72 | issue= 3 | pages= 826-35 | pmid=6309911 | doi=10.1172/JCI111053 | pmc=1129247 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6309911  }} </ref>


=== '''Osteogenesis imperfecta''' ===
=== '''Osteogenesis imperfecta''' ===
[[Osteogenesis imperfecta]] is mainly induced by defect in synthesis of [[Type-I collagen|collagen type I]] along with improper [[Osteoblast|osteoblasts]] functioning. [[Short stature]], [[scoliosis]], tooth defects, hearing defects, blue [[sclera]], and propensity for [[Bone fracture|fractures]] are the main clinical features of the [[disease]].<ref name="pmid19878741">{{cite journal |vauthors=Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM |title=Classification of Osteogenesis Imperfecta revisited |journal=Eur J Med Genet |volume=53 |issue=1 |pages=1–5 |year=2010 |pmid=19878741 |doi=10.1016/j.ejmg.2009.10.007 |url=}}</ref>
* [[Osteogenesis imperfecta]] is mainly induced by defect in the synthesis of [[Type-I collagen|collagen type I]] along with improper [[Osteoblast|osteoblasts]] functioning.  
* [[Short stature]], [[scoliosis]], tooth defects, hearing defects, blue [[sclera]], and propensity for [[Bone fracture|fractures]] are the main clinical features of the [[disease]].<ref name="pmid19878741">{{cite journal |vauthors=Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM |title=Classification of Osteogenesis Imperfecta revisited |journal=Eur J Med Genet |volume=53 |issue=1 |pages=1–5 |year=2010 |pmid=19878741 |doi=10.1016/j.ejmg.2009.10.007 |url=}}</ref>


=== '''Multiple myeloma''' ===
=== '''Multiple myeloma''' ===
[[Multiple myeloma]] is a [[malignant]] proliferation of the [[Plasma cell|plasma cells]], mostly in [[bone marrow]]. It accounts for 40% of all [[bone tumors]]. Diffuse [[bone]] pain and [[tenderness]] are common. Radiologically, osteolytic lesions could be found on the [[bones]]. The [[prognosis]] is poor. [[Chemotherapy]] is the mainstay of treatment.<ref name="pmid12780789">{{cite journal |vauthors= |title=Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group |journal=Br. J. Haematol. |volume=121 |issue=5 |pages=749–57 |year=2003 |pmid=12780789 |doi= |url=}}</ref>
* [[Multiple myeloma]] is a [[malignant]] proliferation of the [[Plasma cell|plasma cells]], mostly in [[bone marrow]].  
* It accounts for 40% of all [[bone tumors]].  
* Diffuse [[bone]] pain and [[tenderness]] are common.  
* Radiologically, osteolytic lesions could be found in the [[bones]].  
* The [[prognosis]] is poor.  
* [[Chemotherapy]] is the mainstay of treatment.<ref name="pmid12780789">{{cite journal |vauthors= |title=Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group |journal=Br. J. Haematol. |volume=121 |issue=5 |pages=749–57 |year=2003 |pmid=12780789 |doi= |url=}}</ref>


=== '''Homocystinuria''' ===
=== '''Homocystinuria''' ===
[[Homocystinuria]] is an [[autosomal recessive]] inherited disorder that affects the metabolism of the [[amino acid]] [[methionine]]. [[Failure to thrive]], visual problems and musculoskeletal problems are the major presentations.<ref name="pmid324277">{{cite journal |vauthors=Grieco AJ |title=Homocystinuria: pathogenetic mechanisms |journal=Am. J. Med. Sci. |volume=273 |issue=2 |pages=120–32 |year=1977 |pmid=324277 |doi= |url=}}</ref>
* [[Homocystinuria]] is an [[autosomal recessive]] disorder that affects the metabolism of the [[amino acid]] [[methionine]].
* Clinical features include [[failure to thrive]], visual and musculoskeletal problems.<ref name="pmid324277">{{cite journal |vauthors=Grieco AJ |title=Homocystinuria: pathogenetic mechanisms |journal=Am. J. Med. Sci. |volume=273 |issue=2 |pages=120–32 |year=1977 |pmid=324277 |doi= |url=}}</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]

Latest revision as of 21:23, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2], Cafer Zorkun, M.D., Ph.D. [3], Raviteja Guddeti, M.B.B.S.[4]

Overview

Osteoporosis must be differentiated from other diseases that cause a decrease in the bone mineral density (BMD), such as idiopathic transient osteoporosis of hip, osteomalacia, scurvy, osteogenesis imperfecta, multiple myeloma, homocystinuria, and hypermetabolic resorptive osteoporosis.

Differentiating Osteoporosis from other Diseases

Osteoporosis must be differentiated from other diseases that cause a decrease in the bone mineral density (BMD), such as idiopathic transient osteoporosis of hip, osteomalacia, scurvy, osteogenesis imperfecta, multiple myeloma, homocystinuria, and hypermetabolic resorptive osteoporosis. The major similarities and differences among the diseases are discussed in the following table:

Diseases History and Physical Examination Imaging findings Laboratory Findings Other Findings
Bone pain Fatigue Short stature Scoliosis Bone tenderness BMD Sub-chondral cortical loss Bone fracture Vitamin C Ca Vitamin D ALKph
Osteoporosis + - + - + ↓↓↓ - + - - -
Idiopathic transient osteoporosis of hip + - - - - ↓↓ + - - - -
Osteomalacia - - - - - - + - -
Scurvy + + - - - - - + - - - -
Osteogenesis imperfecta - - + + - - + - - - -
Multiple myeloma + + - - + - + - - -
Homocystinuria + - - - - - + - - - -

Idiopathic transient osteoporosis of hip

Osteomalacia

  • Osteomalacia is the inability to mineralize the newly formed bone matrix, caused by the deficiency of vitamin D in adults.

Scurvy

Osteogenesis imperfecta

Multiple myeloma

Homocystinuria

References

  1. Balakrishnan A, Schemitsch EH, Pearce D, McKee MD (2003). "Distinguishing transient osteoporosis of the hip from avascular necrosis". Can J Surg. 46 (3): 187–92. PMC 3211740. PMID 12812240.
  2. Hiramatsu R, Ubara Y, Sawa N, Hasegawa E, Kawada M, Imafuku A; et al. (2016). "Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir". Intern Med. 55 (20): 3013–3019. doi:10.2169/internalmedicine.55.6806. PMC 5109571. PMID 27746441.
  3. Chojkier M, Spanheimer R, Peterkofsky B (1983). "Specifically decreased collagen biosynthesis in scurvy dissociated from an effect on proline hydroxylation and correlated with body weight loss. In vitro studies in guinea pig calvarial bones". J Clin Invest. 72 (3): 826–35. doi:10.1172/JCI111053. PMC 1129247. PMID 6309911.
  4. Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM (2010). "Classification of Osteogenesis Imperfecta revisited". Eur J Med Genet. 53 (1): 1–5. doi:10.1016/j.ejmg.2009.10.007. PMID 19878741.
  5. "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group". Br. J. Haematol. 121 (5): 749–57. 2003. PMID 12780789.
  6. Grieco AJ (1977). "Homocystinuria: pathogenetic mechanisms". Am. J. Med. Sci. 273 (2): 120–32. PMID 324277.

​ ​